Oura has acquired the technology and team behind Galen AI, a Stanford-founded AI-powered personal health companion that unifies medical records, labs, medications, and wearable data into a single platform. The acquisition brings Galen AI’s health data integration expertise in-house to accelerate Oura’s AI-powered connected health roadmap.
The core problem Galen AI was built to solve: health information remains siloed across portals, visit notes, prescriptions, and wearable data, making it difficult to see the full picture or understand what’s changing. Galen AI’s infrastructure connects longitudinal health data across tens of thousands of healthcare systems and labs – capability that Oura will now layer on top of its continuous biometric sensing.
“As we shape the next era of Oura, we’re investing in world-class talent to help us push the boundaries of what AI can do for personal health,” said CEO Tom Hale. “Galen AI’s founders bring a rare combination of health domain knowledge, AI expertise, and product vision, strengthening our ability to deliver more personalized, more meaningful health insights to more people.”
The acquisition follows a series of AI-focused moves from Oura, including the recent launch of its first proprietary AI model for women’s health – designed to deliver individualized, clinically grounded guidance around cycles, symptoms, and key life stages – and the acquisition of the Doublepoint team to expand its AI bench. For Oura’s growing female user base (now the majority of new members), the ability to connect clinical data like lab results and prescriptions with continuous biometric data and cycle-phase context could significantly deepen the platform’s women’s health capabilities.
“We started Galen AI to help people make sense of fragmented health data and turn it into meaningful, everyday action,” said co-founder Viraj Mehta. “Joining Oura allows us to bring that work to scale with a team that shares our commitment to clinical rigor and privacy,” added co-founder Priyanka Shrestha.
